Hackensack Meridian Health Mountainside, also known as Mountainside Hospital, is an acute-care hospital located in Montclair, New Jersey, United States. The hospital has 396 beds and serves Northeastern Essex County.

There are 231 beds in Mountainside Hospital.

During the past decade, Mountainside Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 10 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mountainside Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Rutgers, The State University of New Jersey" with 2 trials sponsored, "BioVex Limited" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "GOG Foundation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mountainside Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Rutgers Cancer Institute of New Jersey" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Mountainside Hospital" are "Adenocarcinoma of the Colon" (1 trials), "Adenocarcinoma of the Prostate" (1 trials), "Adenocarcinoma of the Rectum" (1 trials), "Breast Adenocarcinoma" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Mountainside Hospital" in a lesser frequency.

Most popular intervention types in "Mountainside Hospital" are "Drug" (13 trials), "Other" (4 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Quality-of-Life Assessment" (3 trials), "bevacizumab" (2 trials), "fluorouracil" (2 trials) and "leucovorin calcium" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mountainside Hospital" are 10 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Mountainside Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Mountainside Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mountainside Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Mountainside Hospital has several departments that took part in Clinical trials: "Mountainside Hospital Cancer Center" - 10 trials